Thursday October 20, 2022 – 6:00pm – 9:00pm
Wouldn’t it be nice to go to a continuing education program that gives you the tools to be more successful starting on Monday morning? Wouldn’t it be great to be known as the dentist who offers excellent pain-free, post-operative care without the use of narcotics? Wouldn’t you like to be more confident in all of your prescription writing, knowing that you are on the cutting edge, that you are evidence-based and that you are guideline-driven? This is that program.
In 2010, enough opioids were sold to medicate each American adult at a dose of 5mg of hydrocodone every four hours for one month. You do not want to be part of this problem. Remember the Spiderman Principle that, “with great power there must also come – great responsibility.” And what about all of those new antibiotics you keep hearing about? Are they really the latest and greatest? Are there really new guidelines when it comes to antibiotic prophylaxis?
This interactive program looks at the appropriate prescribing of analgesics and antibiotics with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed.
Objectives to be covered:
CDHBC QAP Competency – D1
Mark Donaldson, BSP, RPH, ACPR, PHARMD, FASHP, FACHE
Mark Donaldson received his baccalaureate degree from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and has practiced as a clinical pharmacy specialist, clinical coordinator and director of pharmacy services at many healthcare organizations in both Canada and the United States. He is currently Associate Principal of Pharmacy Advisory Solutions for Vizient, and lives in Whitefish, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon and Adjunct Professor, in the Faculty of Dentistry at the University of British Columbia. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has spent the last 25 years focusing on dental pharmacology and dental therapeutics, and is a leader in the field.
Dr. Donaldson has published numerous peer-reviewed works and textbook chapters. He serves on the Editorial Board for the Journal of the American Dental Association, and is a reviewer for over ten other different journals. He is board certified in healthcare management and is the Past-President and Past-Regent of the American College of Healthcare Executives’ Montana Chapter. Dr. Donaldson is the 2016 recipient of the AGD’s Dr. Thaddeus V. Weclew Award and in 2019 he was conferred by the Canadian Dental Association (CDA) with the, “Special Friend of Canadian Dentistry Award.” This award is given to an individual outside of the dental profession in appreciation for exemplary support or service to the profession as a whole.